Palatin Technologies, Inc. (LON: 0KF3)
London
· Delayed Price · Currency is GBP · Price in USD
1.000
-0.089 (-8.16%)
Jan 22, 2025, 6:37 PM BST
Palatin Technologies Employees
Palatin Technologies had 30 employees as of June 29, 2024. The number of employees decreased by 4 or -11.76% compared to the previous year.
Employees
30
Change (1Y)
-4
Growth (1Y)
-11.76%
Revenue / Employee
59.29K GBP
Profits / Employee
-804.64K GBP
Market Cap
18.28M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
ConvaTec Group | 10,136 |
Hikma Pharmaceuticals | 9,100 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Palatin Technologies News
- 5 weeks ago - Palatin Announces Positive Phase IIb BREAKOUT Study Results in Patients with Type 2 Diabetic Nephropathy - PRNewsWire
- 5 weeks ago - Palatin Technologies announces warrant exercise for ~$3.4M gross proceeds - Seeking Alpha
- 5 weeks ago - Palatin Announces Exercise of Warrants for Approximately $3.4 Million Gross Proceeds - PRNewsWire
- 2 months ago - Palatin Announces Completion of Patient Enrollment in Phase 2 Study of Orally Administered Melanocortin Agonist PL8177 in Ulcerative Colitis - PRNewsWire
- 2 months ago - Palatin Technologies, Inc. (PTN) Q1 2025 Earnings Conference Call Transcript - Seeking Alpha
- 2 months ago - Palatin Reports First Quarter Fiscal Year 2025 Operating/Financial Results - PRNewsWire
- 2 months ago - Palatin to Report First Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on November 14, 2024 - PRNewsWire
- 2 months ago - Palatin Presents Data on Novel Melanocortin 4 Receptor Selective Oral Small Molecule PL7737 Obesity Program at ObesityWeek® 2024 - PRNewsWire